Office for Research
The Office for Research at Idaho State University fosters and maintains mutually beneficial relationships with federal, state and corporate sponsors. We provide high quality and timely service to our faculty and staff while maintaining balance between the interests of ISU, the State of Idaho, and the interests of industry for the public good.
We encompass several areas that handle different parts of the research process. For a variety of research areas including- energy and environmental applications, healthcare, biomedical, geosciences, data assurance - The ISU Office for Research handles the details to assist with projects.
Research Funding - the Sponsored Programs and Support team assists faculty and staff as they develop proposals for external funding for sponsored research, scholarly and community service projects and post-award assistance.
Research Compliance and Requirements - to ensure faculty, staff and students have a general awareness of relevant research compliance rules, understanding of requirements connected to specific research activities and monitoring tools to document ISU's research compliance, the Research Outreach and Compliance team is available for assistance.
Innovation & Collaboration - ISU's talented researchers and students push the boundaries of innovation independently and collaboratively with private-sector partners. To promote scientific developments and develop partnerships the Technology Commercialization office is available to support these endeavors.
One Minute With a Researcher
The Office for Research is proud to present our YouTube series "One Minute with a Researcher" where researchers across campus provide insight into their areas of study.
Research in the News:
Idaho State University wins Idaho Innovation Award for medical isotopes project
Stoel Rives LLP organizes the awards with support from Trailhead and the Idaho Technology Council. ISU was one of five winners announced at the gala event, which was a segment of the Idaho Technology Council’s eighth annual Hall of Fame celebration held at the Boise Centre.
ISU was honored for “A New Process and Mechanism for Producing Copper-67 that enables economical manufacture of Cu-67 in the quantities and purity required for medical testing and life-saving use.”
“We are honored,” said Jon Stoner, deputy director and director of technical operations at the Idaho Accelerator Center (IAC).
On the cutting edge: ISU-Meridian researchers develop method to reduce drug toxicity
Researchers at the Idaho State University-Meridian Health Science Center are a step closer to finding a way to reduce severe side effects caused by powerful drugs used to treat illness and disease.
Biomedical and pharmaceutical sciences assistant professor, Danny Xu, and his team of pharmacy graduate and undergraduate students have developed a computational method that may one day enable doctors to prescribe secondary medications to mitigate the toxicity of the primary drugs used to battle illness. The team’s findings have been published in the prestigious online journal EBioMedicine.
Lead researcher Xu has spent the past two years investigating the primary drug metoclopramide or MCP used to treat severe heartburn and gastroparesis, a digestive disorder that prevents food from leaving the stomach and entering the small intestine properly. Patients suffer from nausea, bloating, stomach pain, vomiting and weight loss.
Idaho State University researchers Robert Holman, Kenneth Rodnick publish research on diabetes
POCATELLO – Chemistry Professor Robert Holman and Biological Sciences Professor Kenneth Rodnick, two researchers from Idaho State University, conducted interdisciplinary research in order to further understand the early chemical processes involved with diabetic complications.
Their article, “A Perspective on Reagent Diversity and Non-covalent Binding of Reactive Carbonyl Species (RCS) and Effector Reagents in Non-enzymatic Glycation (NEG): Mechanistic Considerations and Implications for Future Research,” was recently published in the journal Frontiers in Chemistry.
“Roughly one in 12 individuals in Idaho have diabetes, so the medical cost of this disease is astronomical,” Rodnick said. “There is a big interest in better understanding the progression and complications of diabetes.”
According to Rodnick, diabetics typically have higher levels of glucose in their blood, but glucose can interact with proteins to from permanent structures that modify the structure and function of protein.